Lucentis and Hyperthyroidism - a phase IV clinical study of FDA data

Summary:

Hyperthyroidism is reported only by a few people who take Lucentis.

The study analyzes which people take Lucentis and have Hyperthyroidism. It is created by eHealthMe based on reports of 25,577 people who have side effects while taking Lucentis from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Hyperthyroidism?

Hyperthyroidism (over activity of the thyroid gland) is found to be associated with 989 drugs and 1,435 conditions by eHealthMe. Check the latest studies of Hyperthyroidism.

On Jun, 24, 2026

25,577 people reported to have side effects when taking Lucentis.
Among them, 5 people (0.02%) have Hyperthyroidism.

Among these 5 people:

What is the gender of people who have Hyperthyroidism when taking Lucentis? *

female: 100 %
male: 0.0 %

What is the age of people who have Hyperthyroidism when taking Lucentis? *

What are other drugs people take besides Lucentis? *

Trusopt: 1 person, 20.00%
Micardis: 1 person, 20.00%
Lasix: 1 person, 20.00%
Glucovance: 1 person, 20.00%
Glucophage: 1 person, 20.00%

What are other side effects people have besides Hyperthyroidism? *

Vitamin B12 Deficiency: 1 person, 20.00%
Rickets (softening of bones): 1 person, 20.00%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 1 person, 20.00%
Menstrual Disorder (disease of menstrual cycle): 1 person, 20.00%
Lower Respiratory Tract Infection: 1 person, 20.00%
Iron Deficiency: 1 person, 20.00%
High Blood Pressure: 1 person, 20.00%
Facial Pain: 1 person, 20.00%
Eye Swelling: 1 person, 20.00%
Eye Pain: 1 person, 20.00%

What are the existing conditions these people have? *

Neovascularisation (development of tiny, abnormal, leaky blood vessels inside the eye): 1 person, 20.00%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 1 person, 20.00%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 20.00%
Age-Related Macular Degeneration: 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and have Hyperthyroidism?

- Check whether Hyperthyroidism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lucentis:

Lucentis (25,647 reports)

Hyperthyroidism treatments and more:

Hyperthyroidism (26,832 reports)

Browse all side effects of Lucentis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroidism:

Hyperthyroidism (989 drugs)

Browse all the conditions that are associated with Hyperthyroidism:

Hyperthyroidism (1,435 conditions)

Related publications that referenced our studies

Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .
Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on ranibizumab (the active ingredients of Lucentis) and Lucentis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.